Fig. 2From: Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective studyThe platelet count in patients who received repeated lusutrombopag treatment (n = 13). a–c The platelet count in patients who used lusutrombopag 2 or more times in all patients (n = 13) (a), group A (n = 9) (b), and group B (n = 4) (c). d–f The platelet count in patients who used lusutrombopag 3 or more times in all patients (n = 10) (d), group A (n = 7) (e), and group B (n = 3) (f). *p < 0.05, **p < 0.01. n.s not significant, LUS lusutrombopagBack to article page